Delivery Order SPE2DB22D1106-SPE2DB25FFBQ6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Valganciclovir HCL 50 mg/ml (88 ml) on August 11, 2025, with a ceiling value of $1,024.62. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-competitive set-aside. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valganciclovir 450 mg tablets in quantities of 60 units, with a ceiling value of $12,058.08. This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 21, 2025, with fulfillment performed from AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $4,048.61 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Valganciclovir 450 mg tablets in unit dose packaging of 20s. This is a firm fixed price, competitively awarded contract with no set-aside designation and a performance location in Conshohocken, Pennsylvania. The delivery order is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 units of the medication Valganciclovir 450 mg tablets, with a ceiling value of $2,585.74 and a completion date of July 7, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency Troop Support Medical awarded a $1,047 delivery order to Amerisourcebergen Drug Corporation for 450 mg valganciclovir tablets. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 60 tablets to a location in Conshohocken, Pennsylvania by July 25, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring pharmaceuticals and medical supplies to support military treatment...
- The Defense Logistics Agency awarded a $2,354.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 450 mg valganciclovir tablets. Under this order, Amerisourcebergen will deliver 60 tablets of the specified medication to a location in Conshohocken, Pennsylvania by August 17, 2023 to support the Department of Defense's medical supply needs. As a top pharmaceutical supplier, Amerisourcebergen routinely fulfills delivery orders under the Defense Logistics...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valganciclovir 450 mg tablets. The fixed-price contract has a ceiling value of $1,559.32 and a completion date of February 9, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a...
- The Defense Logistics Agency awarded a $9,909.84 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561769859 VALGANCICLOVIR HCL 50 MG/ML 88ML. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania under a one-day period of performance beginning and ending on August 10-11, 2023. As a component of the U.S. Department of Defense, the Defense Logistics Agency supports...
- The Defense Logistics Agency Troop Support Medical awarded a $778 delivery order to Amerisourcebergen Drug Corporation for 450 mg valganciclovir tablets. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 60 tablets of the generic antiviral medication to a location in Conshohocken, Pennsylvania by September 21, 2023 to support the Defense Logistics Agency's medical supply needs. No set aside provisions or subcontractors were identified. The contract is likely a...
- This is a $2,703.97 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Valganciclovir 450 mg tablets in 60-count packages, with a period of performance through June 9, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFBQ6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Valganciclovir HCl 50 mg/ml in an 88 ml formulation, with a contract ceiling value of $8,470.02 and an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, maintains a significant portfolio of federal medical procurement contracts, particularly with the Defense Logistics Agency and its Medical Supply Chain. The company routinely fulfills delivery orders covering diverse pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support the Defense Health Agency and other government healthcare systems. This specific valganciclovir order exemplifies the company's role in providing critical antiviral medications to support military medical readiness and personnel healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 8/5/25 |